A COMPARISON OF EFFICACY OF ALCOHOL AND PHENOL FOR COELIAC PLEXUS BLOCK IN PATIENTS WITH CHRONIC UPPER ABDOMINAL CANCER PAIN FOR PAIN MANAGEMENT
Abstract
BACKGROUND: Several modalities of chronic pain management for upper abdominal cancers have been proposed. Among all, coeliac plexus block is being widely applied due to its increased success rate. Various techniques and drugs are being tried to improve its accuracy and prolong the duration of analgesic action and thus improve the quality of life of such patients. This is a comparative study between two drugs used for coeliac plexus block.
OBJECTIVES
To compare the efficacy between alcohol and phenol in coeliac plexus block by assessing the pain scores at after the procedure on 1st day, 1week, 1month, 3months, 6months
MATERIALS AND METHODS
Retrospective study consisting of 28 patients with chronic pain due to upper abdominal malignancy, unresponsive to NSAID’s and having severe side effects with strong opioids who underwent coeliac plexus block for pain management.The patients were divided into two groups- Group-A: 14 Patients who underwent Coeliac plexus block with 8% Phenol, Group B: 14 Patients who underwent Coeliac plexus block with 60% alcohol. Pain scores using Numerical Rating Scale (NRS) assessed on the 1st day, 1stweek, at 1st month, 3rd month and 6th month with the help of hospital records were compared between the two groups using mann whitney u test.
RESULTS
The pain scores post procedure on day one, at 1 week, 1 month, 3rd month, 6th month were noted and mean pain scores were 4.92, 3.35, 4.14, 5.85 in group A and 5.07, 3.5, 4.5, 6.28 in group B respectively with p values remained more than 0.05
Conclusion
In our study we found that there was no significant difference in pain outcomes with either alcohol or phenol in patients undergoing coeliac plexus block for chronic/cancer pain management proving them to be equally effective.
Keywords
Full Text:
PDFReferences
Wong GY, Schroeder DR, Carns PE, Wilson JL, Martin DP, Kinney MO, Mantilla CB, Warner DO. Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial. Jama. 2004 Mar 3;291(9):1092-9
Van den Beuken-van Everdingen, M. H. J., De Rijke, J. M., Kessels, A. G., Schouten, H. C., Van Kleef, M., & Patijn, J. (2007). Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Annals of oncology, 18(9), 1437-1449.
Facts, C. (2013). Cancer Facts & Figures 2013. Atlanta: American Cancer Society.
Nagels, W., Pease, N., Bekkering, G., Cools, F., & Dobbels, P. (2013). Celiac plexus neurolysis for abdominal cancer pain: a systematic review. Pain Medicine, 14(8), 1140-1163.
Keefe, F. J., Abernethy, A. P., & C. Campbell, L. (2005). Psychological approaches to understanding and treating disease-related pain. Annu. Rev. Psychol., 56, 601-630.
Zaza, C., & Baine, N. (2002). Cancer pain and psychosocial factors: a critical review of the literature. Journal of pain and symptom management, 24(5), 526-542.
Leung, J. W. C., Bowen‐Wright, M., Aveling, W., Shorvon, P. J., & Cotton, P. B. (1983). Coeliac plexus block for pain in pancreatic cancer and chronic pancreatitis. British journal of surgery, 70(12), 730-732.
Polati, E., Finco, G., Gottin, L., Bassi, C., Pederzoli, P., & Ischia, I. (1998). Prospective randomized double‐blind trial of neurolytic coeliac plexus block in patients with pancreatic cancer. British Journal of Surgery, 85(2), 199-201.
Eisenberg, E., Carr, D. B., & Chalmers, T. C. (1995). Neurolytic celiac plexus block for treatment of cancer pain: a meta-analysis. Anesthesia & Analgesia, 80(2), 290-295.
Koyyalagunta, D., Engle, M. P., Yu, J., Feng, L., & Novy, D. M. (2016). The effectiveness of alcohol versus phenol based splanchnic nerve neurolysis for the treatment of intra-abdominal cancer pain. Pain Physician, 19(4), 281-292.
Romanoski, N. L., Moser, K., & Cherin, N. Chemodenervation and Neurolysis.
Refbacks
- There are currently no refbacks.